The new funding will go toward Vivante Health’s technology upgrades aimed at predicting the onset and progression of GI conditions, according to a Sept. 20 news release from Vivante.
The funding round brings the company’s total capital to $47 million.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.